Woodward Appoints Ron Charles as Chief Human Resources Officer
September 09, 2024 17:33 ET
|
Woodward, Inc.
Woodward appoints Ron Charles as Chief Human Resources Officer
CVG Announces Participation in the Barrington Research Fall Investment Conference
September 09, 2024 17:30 ET
|
Commercial Vehicle Group, Inc.
NEW ALBANY, Ohio, Sept. 09, 2024 (GLOBE NEWSWIRE) -- CVG (NASDAQ: CVGI) announced today that James Ray, President and Chief Executive Officer and Andy Cheung, Executive Vice President and Chief...
UPDATE - Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
September 09, 2024 17:15 ET
|
Aprea Therapeutics
DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology...
Andretti Acquisition Corp. II Completes $230 Million Initial Public Offering
September 09, 2024 17:00 ET
|
Andretti Acquisition Corp. II
INDIANAPOLIS, IN, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Andretti Acquisition Corp. II (the “Company”) announced today the closing of its initial public offering of 23,000,000 units, which includes...
Libtayo® (cemiplimab) Demonstrates Durable Survival Benefit at Five Years in Advanced Non-small Cell Lung Cancer
September 09, 2024 17:00 ET
|
Regeneron Pharmaceuticals, Inc.
Late-breaking data at WCLC show Libtayo monotherapy nearly doubled median overall survival and reduced the risks of death and disease progression by 41% and 50%, respectively, compared to chemotherapy...
Phillips Edison & Company Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 4.950% Senior Unsecured Notes Due 2035
September 09, 2024 16:57 ET
|
Phillips Edison & Company, Inc.
CINCINNATI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality,...
ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)
September 09, 2024 16:47 ET
|
ARS Pharmaceuticals, Inc.
If approved, neffy 1 mg will be the first and only needle-free epinephrine treatment available for younger school-aged children The submission of neffy 1 mg sNDA follows FDA approval on August 9,...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 09, 2024 16:45 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September...
Relay Therapeutics Announces Proposed Public Offering of Common Stock
September 09, 2024 16:34 ET
|
Relay Therapeutics, Inc.
Relay Therapeutics Announces Proposed Public Offering of Common Stock
Jamf Announces Upcoming Conference Participation
September 09, 2024 16:20 ET
|
Jamf
MINNEAPOLIS, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, announced today that members of its management team will present at the...